CeriBell, Inc.

CBLL Healthcare Medical Devices

CeriBell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $89.1 million, up 36.1% from fiscal 2024. In the quarter to June 2026, revenue grew 32.5%, EPS fell 34.2%, free cash flow fell 68.6% and total debt rose 1.52%, each against the same quarter a year earlier.

25.04 2.60 −9.41%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
−10.7×
Dividend yield
—
F-score
4/9
Altman Z
10.80
Beneish M
−2.42
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(43.93%) (37.53%) (30.83%) (373.40%)

+7 more TTM periods

ROA
(35.29%) (30.84%) (25.36%) (42.55%)
ROIC
(229.76%) (207.65%) (229.77%) (231.82%)
Return on Tangible Assets
(46.34%) (39.04%) (31.50%) (29.36%)
Average Days of Receivables
57.26 60.33 61.69 53.92
Free Cash Flow per Share
(1.47) (1.35) (1.16) (1.13)
Free Cash Flow
(56.10) (50.77) (42.33) (41.47)
Other line items

Show all line items

Columns are period end dates